Weight Loss Injection Prices on the NHS and What Private Treatment Costs

Free consultation and clinical review by a GPhC-registered Independent Prescriber, a real clinician reads your answers, not software.
Your prescription and treatment are included in one transparent price, no separate consultation fee, no prescription charge on top.
Free next-working-day tracked delivery by DPD, in plain unbranded packaging.
Priority aftercare available seven days a week, included as standard, no extra charge, no subscription.

On the NHS, weight loss injections are free at the point of use — but strict eligibility criteria and long waiting lists mean most people never reach them. Private treatment is available without a referral, priced per month, and currently ranges roughly £149 to £375 depending on the medicine and dose. These are prescription-only medicines; a clinical assessment is required before any prescription can be issued. The NICE appraisal of tirzepatide (TA1026) and NICE's recommendation for semaglutide (TA875) both outline which patients qualify for NHS access — and the gap between those criteria and what private pharmacies can offer is where most people find themselves.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How NHS and private weight loss injection pricing actually compares in the UK

What NICE guidance says about NHS access, and why most people don't qualify yet

The evidence base for these medicines is substantial. In the SURMOUNT-1 trial, tirzepatide produced an average body-weight reduction of around 20–21% over 72 weeks. Semaglutide 2.4mg (Wegovy) delivered around 15% in the STEP 1 trial. Both figures come from large, well-controlled studies published in the New England Journal of Medicine. That evidence is exactly why NICE recommended both medicines, but the NHS rollout is phased and the thresholds are high.

From June 2025, tirzepatide became available on the NHS for adults with a BMI of 40 or above who also have four or more specific weight-related conditions (high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, or type 2 diabetes). A second cohort (BMI 35 to 39.9 with four or more conditions) became eligible from around June 2026. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. The trajectory is clear, but millions of people with BMIs in the 27–34 range, or fewer qualifying conditions, sit outside these NHS thresholds entirely. For them, cost is not NHS versus private, private is simply the only current route. If you're trying to work out whether you'd qualify and what it might cost through the NHS, our page covering the cheapest weight loss injections available on the NHS sets out the eligibility criteria and what patients are actually paying. You can also read more about what NHS weight loss injection access currently covers if you want the full cohort detail.

How private weight loss injection prices are structured in the UK

Private treatment is priced per pen, which equates to four weeks of treatment. Eli Lilly raised Mounjaro's UK list price from 1 September 2025 (the highest dose's list price moved from around £122 to around £330 per pen) and typical private prices since then have ranged roughly £149 to £375 per month by dose and provider, as widely reported in August 2025. Starting doses cost less than maintenance doses, which matters because treatment usually begins at the lowest strength and is titrated over several months.

That range tells you the floor and ceiling. What it doesn't tell you is what's included. Some providers quote a per-pen price that covers the medicine and nothing else. Consultation fees, prescription fees, and delivery can all be added separately, sometimes bringing the real monthly cost noticeably above the headline figure. One provider charges a consultation on top; another folds it in but charges per dose-review request. It adds up. Our weight loss injections prices page breaks down what each dose tier currently costs and how those figures compare across the main private providers. A full comparison of how private providers structure their costs is also set out on our weight loss injection price comparison page.

What the one price at nume actually covers

A clinician reviews your consultation the same day, before 12pm on a working day means it can be processed in time for same-day dispatch, which is useful if you're arranging delivery around the school run. The pen arrives the next working day via DPD, tracked, in plain packaging. There is no separate consultation charge. No prescription fee. No delivery charge. Aftercare is included seven days a week.

We're not the cheapest option and we don't try to be. That's a deliberate choice. The single price you see on the treatment page is the price, no subscription, no auto-renewal, no hidden additions. Every repeat order is clinically re-reviewed by a prescriber before it goes out. You can learn more about how we work on our about us page, or read about our clinical team via our lead prescriber's profile.

Why 'cheapest' is the wrong question to ask about a prescription medicine

These are Prescription-Only Medicines. UK law requires a prescription following a clinical assessment, and the MHRA has warned publicly about fake weight loss pens being sold online, some containing insulin rather than the medicine on the label. Verified pharmacies are listed on the GPhC register at pharmacyregulation.org; any pharmacy you use should appear there. Prices significantly below the reported market range are a warning sign, not a bargain.

The right question is not which provider is cheapest but which is running a genuinely supervised clinical service through a legitimate supply chain. That means a prescriber who actually reviews your case, medicines sourced through the licensed UK supply chain, and a pharmacy you can verify. Those are the things that keep you safe. For a broader look at where private prices sit across providers and dose levels, the cheapest weight loss injections guide walks through what lower price points usually do and don't include. And if you're weighing up geography alongside cost, our page on weight loss injection prices near you covers how local clinic costs compare with online pharmacy pricing.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions